,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,61176,9,1,,103408666,130792,Unspecified,,,10.0,IC50,In vitro antagonist binding affinity was determined by displacing the [3H]-SCH- in rat striatal Dopamine receptor D1,Confirmatory,,
1,64288,7,2,,103408666,130792,Active,,,0.20199999999999999,IC50,In vitro agonist binding affinity was determined by displacing the [3H]N-propylnorapomorphine ([3H]NPA) in rat striatal Dopamine receptor D2,Confirmatory,,
2,64289,8,5,,103408666,130792,Active,47117674.0,24318.0,2.92,IC50,Displacement of [3H]spiperone from rat striatal Dopamine receptor D2,Confirmatory,,
3,168368,2,4,,103408666,130792,Unspecified,,,,,Tested for % rats with stereotypy at the dose of 20 mg/Kg administered perorally,Other,,
4,176453,5,4,,103408666,130792,Unspecified,,,,,Percent reversal of the increase inDOPA levels in the striatum of GBL-treated rats when administered intraperitoneally was determined,Other,,
5,179793,5,3,,103408666,130792,Unspecified,,,,,Tested for locomotor activity in rat by peroral administration,Other,,
6,184567,2,4,,103408666,130792,Unspecified,,,,,Tested for inhibition of dopamine neuronal firing in rat at the dose of 2.5 mg/Kg by intraperitoneal administration,Other,,
7,1259407,1,1,,363902344,130792,Inactive,,,,,CCRIS mutagenicity studies,Other,,
8,1259407,1,1,,363904648,130792,Inactive,,,,,CCRIS mutagenicity studies,Other,,
